Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Launay-Vacher

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Clinical Nephrology|October 26, 2005
Is low-dose methotrexate nephrotoxic? Case report and review of the literatureH Izzedine, V Launay-Vacher, S Karie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2007
Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendationsV Launay-Vacher, E Chatelut, S M Lichtman, et al.
Terapevticheskii Arkhiv|August 5, 2005
[Pharmacokinetic drug changes in patients with renal failure]S Karie, V Launay-Vacher, N L Kozlovskaia, et al.
American Journal of Nephrology|May 19, 2001
Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic studyH Izzedine, L Mercadal, G Aymard, et al.
Rheumatology (Oxford, England)|February 2, 2008
Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX studyS Karie, F Gandjbakhch, N Janus, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 28, 2009
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]N Janus, V Launay-Vacher, C Robert, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 22, 2003
Medication misuse in hospitalized patients with renal impairmentL Salomon, G Deray, M C Jaudon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)V Launay-Vacher, M Aapro, G De Castro, et al.
British Journal of Cancer|November 11, 2010
Cancer and renal insufficiency results of the BIRMA studyN Janus, V Launay-Vacher, E Byloos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2012
Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) studyN Janus, V Launay-Vacher, A Thyss, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Clinical Nephrology|October 26, 2005
Is low-dose methotrexate nephrotoxic? Case report and review of the literatureH Izzedine, V Launay-Vacher, S Karie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2007
Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendationsV Launay-Vacher, E Chatelut, S M Lichtman, et al.
Terapevticheskii Arkhiv|August 5, 2005
[Pharmacokinetic drug changes in patients with renal failure]S Karie, V Launay-Vacher, N L Kozlovskaia, et al.
American Journal of Nephrology|May 19, 2001
Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic studyH Izzedine, L Mercadal, G Aymard, et al.
Rheumatology (Oxford, England)|February 2, 2008
Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX studyS Karie, F Gandjbakhch, N Janus, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 28, 2009
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]N Janus, V Launay-Vacher, C Robert, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|August 22, 2003
Medication misuse in hospitalized patients with renal impairmentL Salomon, G Deray, M C Jaudon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)V Launay-Vacher, M Aapro, G De Castro, et al.
British Journal of Cancer|November 11, 2010
Cancer and renal insufficiency results of the BIRMA studyN Janus, V Launay-Vacher, E Byloos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2012
Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) studyN Janus, V Launay-Vacher, A Thyss, et al.
Pageof 6